Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Argilés Martinez, Guillem
110  Ergebnisse:
Personensuche X
?
1

Prognostic Nomogram and Patterns of Use of FOLFIRI-Afliberc..:

Fernández Montes, Ana ; López López, Carlos ; Argilés Martínez, Guillem...
The Oncologist.  24 (2019)  8 - p. e687-e695 , 2019
Link: https://doi.org/10.1634/..
 
?
2

Establishment of patient-derived tumor organoids to functio..:

MARTINI, Giulia ; belli, valentina ; Napolitano, Stefania...
ESMO Open;8(3).  , 2023
Link: https://hdl.handle.net/1..
 
?
3

Tumor-intrinsic expression of the autophagy gene Atg16l1 su..:

Taraborrelli, Lucia ; Şenbabaoğlu, Yasin ; Wang, Lifen...
Nature Communications;14.  , 2023
Link: https://hdl.handle.net/1..
 
?
4

A Comprehensive Biomarker Analysis of Microsatellite Unstab..:

Elez Fernandez, Mª Elena ; Mulet Margalef, Núria ; Sanso Martinez, Miriam...
International Journal of Molecular Sciences;24(1).  , 2022
Link: https://hdl.handle.net/1..
 
?
5

A randomised phase 2 study comparing different dose approac..:

Argilés Martinez, Guillem ; Mulet Margalef, Nuria ; Valladares-Ayerbes, Manuel...
European Journal of Cancer;177.  , 2022
Link: https://hdl.handle.net/1..
 
?
6

A randomised phase 2 study comparing different dose approac..:

Argilés Martínez, Guillem ; Mulet, N ; Valladares-Ayerbes, M...
European journal of cancer.  , 2022
Link: https://ddd.uab.cat/reco..
 
?
7

First-line trifluridine/tipiracil + bevacizumab in patients..:

Van Cutsem, Eric ; Danielewicz, I ; Saunders, M. P...
British Journal of Cancer;126.  , 2022
Link: https://hdl.handle.net/1..
 
?
8

Early Clinical Experience with Trifluridine/Tipiracil for R..:

García-Alfonso, Pilar ; Muñoz, Andrés ; Jiménez-Castro, Jerónimo...
Cancers.  13 (2021)  18 - p. 4514 , 2021
Link: https://doi.org/10.3390/..
 
?
9

Early Clinical Experience with Trifluridine/Tipiracil for R..:

Muñoz, Andrés ; Jiménez-Castro, Jerónimo ; Jimenez-Fonseca, Paula...
Cancers;13(18).  , 2021
Link: https://hdl.handle.net/1..
 
?
10

BRAF, MEK and EGFR inhibition as treatment strategies in BR..:

Ros Montañá, Fco. Javier ; Baraibar Argota, Iosune ; Sardo, Emilia...
Therapeutic Advances in Medical Oncology;13.  , 2021
Link: https://hdl.handle.net/1..
 
?
11

Trifluridine/tipiracil in combination with oxaliplatin and ..:

Bordonaro, R ; Calvo, A ; Auriemma, A...
ESMO Open;6(5).  , 2021
Link: https://hdl.handle.net/1..
 
?
12

Trifluridine/tipiracil plus bevacizumab in patients with un..:

Van Cutsem, Eric ; Danielewicz, I ; Saunders, M. P...
Annals of Oncology;31(9).  , 2020
Link: https://hdl.handle.net/1..
 
?
13

Neutropenia and survival outcomes in metastatic colorectal ..:

Yoshino, T ; Cleary, J. M ; Van Cutsem, Eric...
Annals of Oncology;31(1).  , 2020
Link: https://hdl.handle.net/1..
 
?
14

Antitumor activity of ipatasertib combined with chemotherap..:

Isakoff, S. J ; Tabernero Caturla, Josep ; Molife, L. R...
Annals of Oncology;31(5).  , 2020
Link: https://hdl.handle.net/1..
 
?
15

Molecular subtypes and the evolution of treatment managemen..:

Martini, Giulia ; Ros Montañá, Fco. Javier ; Baraibar Argota, Iosune...
Therapeutic Advances in Medical Oncology;12.  , 2020
Link: https://hdl.handle.net/1..
 
1-15